TY - JOUR
T1 - Perioperative Coronavirus Vaccination—Timing and Implications
T2 - A Guidance Document
AU - Society of Thoracic Surgeons Workforce on Critical Care
AU - Merritt-Genore, Helen Mari
AU - Moosdorf, Rainer
AU - Gillaspie, Erin
AU - Lother, Sylvain
AU - Engelman, Daniel
AU - Ahmed, Shahnur
AU - Baciewicz, Frank A.
AU - Grant, Michael C.
AU - Milewski, Rita
AU - Cawcutt, Kelly
AU - Hayanga, J. Awori
AU - Chatterjee, Subhasis
AU - Arora, Rakesh C.
N1 - Funding Information:
This guidance document was developed by The Society of Thoracic Surgeons Workforce on Critical Care, which focuses on the identification and assessment of issues of concern to surgeons who perform critical care. The authors acknowledge The Society of Thoracic Surgeons Workforce on Adult Cardiac and Vascular Surgery and General Thoracic Surgery for their review and support of this work. The authors also acknowledge particular members of the Workforce on Critical Care for efforts in finalizing the document: Cory Alwardt, Michael Firstenberg, Charles Geller, Hitoshi Hirose, Francis Lytle, Nathalie Roy, Michael Wall, and Thomas Washburn.
Publisher Copyright:
© 2021 The Society of Thoracic Surgeons
PY - 2021/11
Y1 - 2021/11
N2 - Executive Summary: Cardiothoracic surgical patients are at risk of increased coronavirus disease severity. Several important factors influence the administration of the coronavirus disease vaccine in the perioperative period. This guidance statement outlines current information regarding vaccine types, summarizes recommendations regarding appropriate timing of administration, and provides information regarding side effects in the perioperative period for cardiac and thoracic surgical patients.
AB - Executive Summary: Cardiothoracic surgical patients are at risk of increased coronavirus disease severity. Several important factors influence the administration of the coronavirus disease vaccine in the perioperative period. This guidance statement outlines current information regarding vaccine types, summarizes recommendations regarding appropriate timing of administration, and provides information regarding side effects in the perioperative period for cardiac and thoracic surgical patients.
UR - http://www.scopus.com/inward/record.url?scp=85114703123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114703123&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2021.07.016
DO - 10.1016/j.athoracsur.2021.07.016
M3 - Article
C2 - 34370980
AN - SCOPUS:85114703123
VL - 112
SP - 1707
EP - 1715
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
SN - 0003-4975
IS - 5
ER -